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METHODOLOGY Open Access
Measuring the impact of methodological
research: a framework and methods to identify
evidence of impact
Valerie C Brueton, Claire L Vale*, Babak Choodari-Oskooei, Rachel Jinks and Jayne F Tierney
Abstract
Background: Providing evidence of impact highlights the benefits of medical research to society. Such evidence is
increasingly requested by research funders and commonly relies on citation analysis. However, other indicators may
be more informative. Although frameworks to demonstrate the impact of clinical research have been reported, no
complementary framework exists for methodological research. Therefore, we assessed the impact of methodological
research projects conducted or completed between 2009 and 2012 at the UK Medical Research Council Clinical Trials
Unit Hub for Trials Methodology Research Hub, with a view to developing an appropriate framework.
Methods: Various approaches to the collection of data on research impact were employed. Citation rates were
obtained using Web of Science (http://www.webofknowledge.com/) and analyzed descriptively. Semistructured
interviews were conducted to obtain information on the rates of different types of research output that indicated
impact for each project. Results were then pooled across all projects. Finally, email queries pertaining to methodology
projects were collected retrospectively and their content analyzed.
Results: Simple citation analysis established the citation rates per year since publication for 74 methodological
publications; however, further detailed analysis revealed more about the potential influence of these citations.
Interviews that spanned 20 individual research projects demonstrated a variety of types of impact not otherwise
collated, for example, applications and further developments of the research; release of software and provision of
guidance materials to facilitate uptake; formation of new collaborations and broad dissemination. Finally, 194 email
queries relating to 6 methodological projects were received from 170 individuals across 23 countries. They provided
further evidence that the methodologies were impacting on research and research practice, both nationally and
internationally. We have used the information gathered in this study to adapt an existing framework for impact of
clinical research for use in methodological research.
Conclusions: Gathering evidence on research impact of methodological research from a variety of sources has
enabled us to obtain multiple indicators and thus to demonstrate broad impacts of methodological research. The
adapted framework developed can be applied to future methodological research and thus provides a tool for
methodologists to better assess and report research impacts.
Keywords: Framework, impact measurement, methodological research, methodology
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Background
For the benefits of research to be demonstrated to soci-
ety, researchers are increasingly being asked to demon-
strate not just the outputs of their research, but also
measures of its impact. For example, many funding bod-
ies require researchers to demonstrate the impacts of
their completed research, whilst others, including the
UK Medical Research Council (MRC), expect all new
funding applications to outline their plans to measure
impact. Approaches to demonstrating and measuring
the impact of clinical research have been reported [1-3]
and a framework has been proposed [4]. This frame-
work, the Becker model, categorizes different types of
research output, such as development of collaborations
or different ways of disseminating research to demon-
strate such impacts as advancement of knowledge and
implementation.
In 2008, the UK MRC Clinical Trials Unit (CTU) be-
came one of eight regional hubs for trials methodology
research. Methodological research conducted by the
MRC CTU Hub is primarily designed to develop re-
search methods, to improve the quality and consistency
of research practice in three areas: applied statistical meth-
odology, trial-conduct methodology and meta-analysis
methodology. Guidance on the application of the methods
developed is also provided, to improve the quality and reli-
ability of research both within the MRC CTU and else-
where. There is also a need to demonstrate the impact of
methodological research, but, to our knowledge, no tool
exists for the measurement of such impact. Therefore, we
aimed to identify ways to assess indicators of impacts be-
yond simply identifying publication and citation rates of
our research.
Methods
To quantify a variety of impact indicators, we used three
separate approaches. The first of these was focused on
standard indicators relating to publications and citations
of published research. We also used interviews to ex-
plore other indicators, such as collaborations, wider dis-
semination and knowledge transfer. Finally, we sought
evidence of implementation of the research, both through
the interviews and also through the analysis of email quer-
ies. Application of the NHS REC Health Research Author-
ity decision-making tool [5] indicated that because our
research was not a clinical trial of a medicinal product or
device; no clinical data were collected and the interviewees
were neither trial participants nor NHS patients, ethics ap-
proval was not necessary (Additional file 1) and on this
basis, was not sought. The study did not receive specific
funding, but was conducted in the full knowledge of the
MRC CTU senior management group. Furthermore, the
researchers who agreed to participate in the interviews to
evaluate impact of the Unit’s methodological research are
fully aware and supportive of the results being written up
for publication.
Citation analysis
We identified all CTU methodology publications in peer-
reviewed journals dating from 01 January 2009 to 31
December 2012. For each eligible publication, we ex-
tracted the full publication and journal title, journal
impact factor, publication date, and the theme of the
methodological research (for example, applied statistical
methodology). This information was logged, along with
citation counts obtained from the Web of Science [6], and
is up to date as of 11 December 2013. We also used the
Web of Science to explore the citations of the eligible pub-
lications, for example assessing whether the citations were
found in original research (for example, a clinical trial
publication) or review articles (for example, a review of
different methodologies). We also noted the clinical or
academic discipline of the citing articles. To allow for the
range of publication dates, average annual citation rates
for each publication were calculated from the total num-
ber of citations and the date of first publication (either on-
line or in print). Publications that were too recent to have
been included, and those published in journals that are
not catalogued in Web of Science, were necessarily ex-
cluded from these calculations. Journals were grouped into
broad categories, such as statistics, clinical trials and gen-
eral medical for ease of analysis. The data were exported
into Stata [7] for descriptive statistical analysis.
Interviews
We identified a sampling frame of ongoing or completed
methodology projects for the period January 2009 to
December 2012 and a corresponding sample of the
MRC CTU Hub methodologists who had led these pro-
jects. Each methodologist was invited for interview via
email. Information about the study aims, focus and
interview length was provided in the invitation email.
Each interviewee gave written permission via email to be
interviewed; this was taken as consent to study participa-
tion. Each interview was held at a time and place conveni-
ent to the participant. The interviews were conducted by
one author with interview experience (VCB) at a place
and time convenient to the methodologist.
To obtain quantitative information on the frequency
and variety of indicators of the impacts of each methodo-
logical research project, we developed a semistructured
interview schedule. The schedule included questions on
dissemination, production of software or guidance docu-
ments, teaching and workshops and changes in practice
relating to the research (Additional file 2). Interviewees
were asked to identify the number of impacts, if any, under
each category. As peer-reviewed articles were examined
separately, we purposefully did not ask about publications
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during the interview. Pilot interviews using the draft inter-
view schedule were conducted with two methodologists.
The schedule was subsequently revised and finalized fol-
lowing one further pilot interview. Data from pilot inter-
views were included in the final dataset for analysis.
Contemporaneous written notes of each interview were
taken by the interviewer (VCB) and a second author
(CLV). The interviews were not recorded. The notes were
checked and any queries were resolved between two au-
thors (VCB, CLV). Unresolved data queries were sent back
to the interviewee to be resolved and final summaries of
each interview were returned to each interviewee for val-
idation. Finally, data for each unique methodology project
were extracted from verified interview notes using a stand-
ard data extraction form and entered into a Microsoft
Excel spreadsheet for data management. For some pro-
jects, this meant combining quantitative data from mul-
tiple interviewees. Final data for each project were
analyzed using Stata [7]. For the analysis, some additional
grouping was made for questions about geographic lo-
cation (for example, location of collaborators or confer-
ences, or where new methods developed have been
adopted), the answers were grouped as: internal, na-
tional (within the UK) or international (outside of the
UK). Where multiple locations were given, the furthest
afield was used to define the category. The data for
meetings, workshops and lectures were combined into
one variable for reporting, as it was felt that there was
considerable overlap in how they were described by the
interviewees.
Email analysis
Methodologists who indicated that they received email
queries about their research were asked to supply these
emails to a central mail box. The content of each email
was evaluated by two authors (CLV, BC-O). Data on the
subject of the email, the date received, and the location
and institution of the individual initiating the query were
recorded for descriptive analysis.
Results
Publications and citations
We identified 74 eligible peer-reviewed publications,
most of which were published in either statistics journals
(n = 26), clinical trials journals (n = 12), disease-specific
or general medical journals (n = 20, Figures 1 and 2).
Eight articles (11%) had not yet been cited, however
most of these had only been published in 2012. More
than half of all publications (n = 43, 58%) had been cited
fewer than four times per year, with the remaining publi-
cations (n = 23, 31%) having been cited more frequently
(Figure 3).
More detailed mapping of the four most highly cited
publications showed that these four articles [8-11] were
subsequently cited in original research articles (for ex-
ample, clinical trials, cohort studies), and in review arti-
cles, editorials and letters spanning a number of fields,
including general internal medicine, cardiovascular dis-
ease, cancer, and orthopaedics.
Interviews
Fourteen interviews were conducted with methodolo-
gists at the MRC CTU hHub between June and October
2012. The interviewees spanned the three research
themes and were linked to 20 individual projects. Most
were in the area of statistical methodology (n = 13), with
the remaining projects representing trial-conduct meth-
odology (n = 6) and meta-analysis methodology (n = 1,
Table 1). For three projects (for example, the multi-arm
multi-stage trial design), information came from several
interviewees (Table 1).
Table 2 summarizes research outputs for the 20 pro-
jects identified. These projects led to several conference
presentations, lectures and collaborations.
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Top journals for Hub methodology papers
2009-2012
Figure 1 Journals in which MRC CTU methodology papers were most frequently published, 2009 to 2012 (top 63% of all articles).
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Dissemination
Books and grey literature publications
Two books relating to statistical methodology were pub-
lished within the timeframe. In addition, three pieces of
online guidance were produced, two on involvement of
patients and the public in clinical trials and systematic
reviews [12,13] and the third on the assessment of risk
in the management and monitoring of clinical trials [14].
Conference presentations
In total, there were 42 presentations at both national
and international conferences relating to 14 of the 20
projects (70%, Table 2). Five projects were presented at
national conferences only, five projects were presented
at international conferences and four projects were pre-
sented at both national and international conferences.
Conferences were usually methodology-themed (for ex-
ample, the International Society for Clinical Biostatistics
and the UK Clinical Trials Methodology conference) or
disease-specific (for example, the British Gynaecological
Cancer Society). Six projects had not yet been presented
at any conferences. It was unclear whether they were
likely to be presented in the future.
In addition to presentations at conferences, 17 of 20
(85%) projects had been presented or discussed in lec-
tures, meetings or workshops between 2009 and 2012,
mostly (n = 16, 94%) outside of the MRC CTU. Three
statistical methodology projects had been included in
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2009-2012
Figure 2 Journal types publishing MRC CTU Hub methodology papers (2009 to 2012).
Figure 3 Average number of citations per publication per year (2009 to 2013).
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more than 19 meetings, lectures or workshops within
the timeframe.
Software and training materials produced
Of the 20 included projects, 8 (40%) had developed stat-
istical software (Stata [7]); 6 (30%) had produced training
materials and 3 (15%) had produced both software and
guidance to enable the methodology to be better applied.
For eight of the projects that had developed software
that had been made freely available, interviewees noted
that these were being commonly used, both within the
MRC CTU Hub and externally.
Impacts on methodological research or practice
Of the 20 projects 12 (60%) provided evidence that they
had influenced changes in research practice. Five projects
reported changing research practice within the MRC CTU
Huband a further seven projects reported changing prac-
tice outside the MRC CTU Hub. All of the projects that
had produced statistical software or training materials
(n = 8) were reported to have changed practice at the
MRC CTU, and these methods were also currently being
applied in ongoing projects being run through the MRC
CTU. Five projects that had not produced software or
training materials also reported changes to the way data
were analyzed. For the remaining three projects, it was
thought to be too early to show any evidence of a
change in practice or it was unclear at the time of inter-
view whether practice had changed.
Methodology projects leading to new research or
collaborations
Methodologists reported that over half of the method-
ology projects (n = 12) led to a new research project.
The new follow-on projects reported were mainly in the
area of statistical methodology (n = 8), with fewer in trial-
conduct methodology (n = 3) or meta-analysis method-
ology (n = 1). Furthermore, five statistical methodology
projects had led to PhD studentships to further develop
the methodology.
Methodologists also reported 29 external collabora-
tions relating to 12 of the 20 projects. The majority of
Table 1 Methodology projects
Project title Methodology area Interviewee number*
Flexible parametric models Statistical 13
Missing data for prognostics Statistical 13
Multi-variable modelling, prognostic modelling Statistical 13
Modelling the association between patient characteristics and change over time in a disease measure Statistical 3
Combining multiple imputation and inverse probability weighting Statistical 3
New measure of the predictive ability for a survival model Statistical 7
Bias two-arm multi-stage trials Statistical 7
Analysis of resources for trials Statistical 8
Restricted mean survival time Statistical 4
Multi-arm multi-stage trial design Statistical 5, 10
Biomarkers Statistical 4
Comparing dynamic treatment regimens or monitoring strategies Statistical 11, 12
Estimating the effect of time-varying treatment or exposure on outcome Statistical 11, 12
Developing guidance for researchers on patient and public involvement in clinical research Trial conduct 2
Consumer involvement in MRC CTU studies Trial conduct 2
DAMOCLES (DAta MOnitoring Committees: Lessons, Ethics, Statistics) Trial conduct 5
Retention strategies for randomized trials Trial conduct 14
Central monitoring techniques to replace on-site monitoring Trial conduct 6
Risk-based monitoring of trials Trial conduct 9
Analysis of subgroup interactions in individual patient data meta-analysis Meta-analysis 1
Total 20 14
*Interviewees 2, 3, 4, 5, 7, 11, 12 and 13 discussed more than one project. CTU, clinical trials unit; MRC, UK Medical Research Council.
Table 2 Research outputs identified through interviews
Research output Total Range per
project
Median per
project
Meetings 1 — —
Workshops 10 1 to 3 1
Lectures 32 1 to 10 2
Conference presentations 42 1 to 18 2
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these 12 projects had three collaborations or fewer. Col-
laborations were largely with other researchers based
within the UK; however, four projects had led to inter-
national collaborations with research institutions and uni-
versities in France, Germany, Netherlands and the USA.
Email analysis
Most of the methodologists interviewed had not received
email queries about their work; however four methodolo-
gists were able to supply them for this analysis. As the
emails were collected retrospectively, and had not neces-
sarily been saved systematically by the four individuals,
they did not cover the whole time period from January
2009 to December 2012. However, the available email data
comprised 194 queries received from 170 individuals across
23 countries in Europe, North America, Asia and beyond.
The queries related to six research projects and commonly
sought clarification about application of the specific meth-
od, or use of accompanying computer software. Some
emails requested further information or advice relating to
further development or novel applications of the method.
Developing a framework for reporting impact: case study
Using the three methods, we identified a range of key in-
dicators that illustrate the impact of our methodological
research and have used them to develop a framework,
based on the Becker model [4]. The collection of evi-
dence of collaboration, teaching (lectures, workshops
and PhD studentships), dissemination (conference pre-
sentations and publications), applications (statistical soft-
ware and guidance documents) and changes in research
practice (that is, examples of trials from within the MRC
CTU and from other organizations that have adopted
this design) has enabled us to demonstrate a range of
impacts, including research outputs and activities; ad-
vancement of knowledge, and implementation. Figure 4
shows this framework and summarizes the impacts at-
tributable to the multi-arm multi-stage trial design pro-
ject [15-17]. This framework will now be used to collate
and better report impact for future and ongoing meth-
odology studies.
Discussion
The use of three approaches illustrated a variety of impact
indicators in addition to numbers of publications and sub-
sequent citations. The rich quality of information gathered
from interviews with methodologists enabled us to better
identify indicators of impact that had not otherwise been
collated, such as advancement of knowledge (illustrated
through collaboration, workshops and seminars) and im-
plementation (demonstrated by the application of new
methods within new trials). The implementation of meth-
odological research was aided by the provision of statis-
tical software, training materials and books. Content
analysis of email queries received by some methodologists
also gave a broad demonstration of the methodological re-
search being used in further research and practice.
Collating information about methodological research
outputs and linking these outputs to the different types
of impact they indicate has allowed us to better under-
stand the impacts of our methodological research to
date. Obviously, these data are not exhaustive, being lim-
ited only to projects being led within the MRC CTU.
Furthermore, because the data were retrospective, they
might not always be complete or consistent. In addition,
data from the three approaches does not always link to
the same group of projects; for example, publications in-
cluded in the sample relate to many more projects than
Advancement of 
knowledge
Collaborations
Academic institutions
UK / Europe (n=3)
Teaching
Lectures / 
Seminars(n=2)
Workshops (n=3)
PhD studentships n=1)
Dissemination
Conference
Presentations (n=18)
Publications (n=7)*
Application
Statistical software 
developed and 
released 
Change in
practice
New MAMS trials 
being set up 
internally and 
externally
Implementation
Impact category Indicator of 
impact
Evidence of impact
(research outputs)
Figure 4 Impacts for the MRC CTU Hub multi-arm multi-stage trial design 2009 to 2012. *Publications from 2008 to 2013 only.
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the 20 projects for which interviews were conducted.
Similarly, the data from emails relate to only six projects
in total. However, having identified the value in collect-
ing these data, we hope to move towards developing a
systematic prospective collection of a set of core routine
data for all projects.
We are not aware of any other prior work that aimed
to assess the impact of methodology research, neither
could we identify any model or framework for assessing
such impacts. However, similar methods to the multi-
method approach that we used have been used for clinical
research [4], and resulted in a framework, the Becker
model. This was designed to measure impact, demon-
strated through research outputs and other indicators of
clinical research, in key themes, including research out-
puts, advancement of knowledge, implementation of
findings, community benefit, legislation and policy, and
economic benefit. Whilst perhaps not all of these impacts
apply to methodological research, there are some areas of
overlap. We found evidence from our three approaches to
support impact relating to three areas included in the
Becker model: research output, advancement of know-
ledge and implementation of findings. We therefore sug-
gest this as a basic framework for demonstrating impact of
methodological research, as shown in the example of the
multi-arm multi-stage trial design.
An increasing number of public sector and academic
funders now require evidence of research impact. The
methods we used provided a useful way of identifying
broader application of the research methodologies be-
yond citation analysis. In addition, measuring the impact
of our research has enabled us to review the projects
with the highest impacts and to learn from these. For ex-
ample, we found that all of the projects that released
freely available accompanying software could demon-
strate implementation through the use of the software,
which had enabled others to readily apply the method-
ology. We are currently investigating ways to optimise
impact across all areas of methodological research.
Conclusions
Gathering evidence through analysis of publications and
their citations, semistructured interviews and analysis of
research queries enabled us to obtain multiple indicators
and thus to demonstrate broad impacts of methodological
research. Collating evidence of impact has enabled us to
adapt a framework that may be broadly applied to future
methodological research; provide reports to funders; dem-
onstrate impact of our research more broadly and, finally,
be applied by other researchers.
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